GST 2.0 will make cancer treatment cheaper: Life-saving drugs for cancer and chronic diseases exempted from GST | – The Times of India

The rollout of GST 2.0 from 22 September 2025 marks a major relief for patients battling cancer and other chronic illnesses in India. Under the revised GST regime, 33 life-saving drugs and medicines have been exempted from GST, while three critical drugs used for cancer, rare diseases, and severe chronic conditions are also taxed at…

GST 2.0 In Focus: Time For Investors To Rejig Portfolios Toward FMCG, Auto & Tyres?

Last Updated:September 03, 2025, 13:22 IST GST Council meet may bring key reforms, boosting autos, consumer durables & discretionary consumption sectors; Key points for investors GST Council Meet Strong enough to partially cushion the blow of Donald Trump’s proposed 50% tariff on Indian goods, the upcoming Goods and Services Tax (GST) reforms could be a…

News18

GST 2.0: States projected to gain Rs 14.1 lakh crore from revenues; SBI Research backs rationalisation – The Times of India

States are set to emerge as “net gainers” under the planned Goods and Services Tax (GST) rate overhaul, with collections including devolution likely to cross Rs 14.10 lakh crore this fiscal, SBI Research has projected in its latest report.The study underlined that earlier rounds of rate cuts in 2018 and 2019 triggered a short-term dip…